SAMBA HIV semiquantitative test, a new point-of-care viral-load-monitoring assay for resource-limited settings

Journal of Clinical Microbiology

Volumn 52, Issue 9, 2014, Pages 3377-3383

  Ritchie, Allyson V ^a   Ushiro Lumb, Ines ^b,e   Edemaga, Daniel ^c   Joshi, Hrishikesh A ^a,f   De Ruiter, Annemiek ^d   Szumilin, Elisabeth ^c   Jendrulek, Isabelle ^d   McGuire, Megan ^c   Goel, Neha ^a   Sharma, Pia I ^a,g   Allain, Jean Pierre ^a   Lee, Helen H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e NHS BLOOD AND TRANSPLANT   (United Kingdom)

^f ILLUMINA INC   (United States)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; COMPARATIVE STUDY; DRUG MONITORING; EVALUATION STUDY; FEMALE; HIV INFECTIONS; HOSPITAL INFORMATION SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; MALAWI; MALE; MIDDLE AGED; PROCEDURES; UGANDA; UNITED KINGDOM; VIROLOGY; VIRUS LOAD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DRUG MONITORING; FEMALE; GREAT BRITAIN; HIV INFECTIONS; HIV-1; HUMANS; LONDON; MALAWI; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; UGANDA; VIRAL LOAD; YOUNG ADULT;

EID: 84906857916     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00593-14     Document Type: Article

References (23)

1. WHO. 2013. HIV/AIDS: data and statistics. World Health Organization, Geneva, Switzerland.
2. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR, HPTN 052 Study Team. 2011. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 365: 493-505. http://dx.doi.org/10.1056/NEJMoa1105243.
3. United Nations. 2011. Political declaration on HIV/AIDS: Intensifying our efforts to eliminate HIV/AIDS. United Nations.
4. Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankale JL, Dieng-Sarr A, Agbaji O, Onwujekwe DI, Gashau W, Nkado R, Ekong E, Okonkwo P, Murphy RL, Kanki PJ. 2011. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clin. Infect. Dis. 53:1283-1290. http://dx.doi.org/10.1093/cid/cir729.
5. Fox MP, Cutsem GV, Giddy J, Maskew M, Keiser O, Prozesky H, Wood R, Hernán MA, Sterne JA, Egger M, Boulle A, IeDEA-SA Collaboration. 2012. Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa. J. Acquir. Immune Defic. Syndr. 60:428-437. http://dx.doi.org/10.1097/QAI.0b013e3182557785.
6. Keiser O, Chi BH, Gsponer T, Boulle A, Orrell C, Phiri S, Maxwell N, Maskew M, Prozesky H, Fox MP, Westfall A, Egger M. 2011. Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa. AIDS 25:1761-1769. http://dx.doi.org/10.1097/QAD. 0b013e328349822f.
7. Lawn SD, Bekker LG, Calmy A, Wood R. 2008. Monitoring of antiretroviral therapy in low-resource settings. Lancet 372:287-289. http://dx.doi.org/10.1016/ S0140-6736(08)61101-0.
8. WHO. 2013. Consolidated ARV guidelines. World Health Organization, Geneva, Switzerland.
9. Gallant J, Mehta SH, Sugarman J. 2013. Universal antiretroviral therapy for HIV infection: should US treatment guidelines be applied to resource-limited settings? Clin. Infect. Dis. 57:884-887. http://dx.doi.org/10.1093/cid/cit382.
10. Stephenson J. 2002. Cheaper HIV drugs for poor nations bring a new challenge: monitoring treatment. JAMA 288:151-153. http://dx.doi.org/10.1001/ jama.288.2.151. (Pubitemid 34755267)
11. Fiscus SA, Cheng B, Crowe SM, Demeter L, Jennings C, Miller V, Respess R, Stevens W. 2006. HIV-1 viral load assays for resource-limited settings. PLoS Med. 3:e417. http://dx.doi.org/10.1371/journal.pmed.0030417.
12. Usdin M, Guillerm M, Calmy A. 2010. Patient needs and point-of-care requirements for HIV load testing in resource-limited settings. J. Infect. Dis. 201(Suppl 1):S73-S77. http://dx.doi.org/10.1086/650384.
13. Calmy A, Klement E, Teck R, Berman D, Pécoul B, Ferradini Laurent C. 2004. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling up. AIDS 18:2353-2360. (Pubitemid 40065902)
14. WHO, UNAIDS. 2011. The treatment 2.0 framework for action: catalysing the next phase of treatment, care and support. World Health Organization, Geneva, Switzerland.
15. Lee HH, Dineva MA, Chua YL, Ritchie AV, Ushiro-Lumb I, Wisniewski CA. 2010. Simple amplification-based assay: a nucleic acid-based point-of-care platform for HIV-1 testing. J. Infect. Dis. 201(Suppl 1):S65-S72. http://dx.doi.org/10.1086/650385.
16. National Department of Health. 2010. Clinical guidelines for the management of HIV & AIDS in adults and adolescents. National Department of Health, Pretoria, South Africa.
17. WHO. 2010. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. World Health Organization, Geneva, Switzerland.
18. Lee PK, Kieffer TL, Siliciano RF, Nettles RE. 2006. HIV-1 viral load blips are of limited clinical significance. J. Antimicrob. Chemother. 57:803-805. http://dx.doi.org/10.1093/jac/dkl092.
19. Nettles RE, Kieffer TL, Kwon P, Monie D, Han Y, Parsons T, Cofrancesco J, Jr, Gallant JE, Quinn TC, Jackson B, Flexner C, Carson K, Ray S, Persaud D, Siliciano RF. 2005. Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART. JAMA 293:817-829. http://dx.doi.org/10.1001/jama.293. 7.817. (Pubitemid 40250365)
20. Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, Karungi G, Szumilin E, Balandine S, Fedida G, Carrieri MP, Spire B, Ford N, Tassie JM, Guerin PJ, Brasher C. 2006. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 367:1335-1342. http://dx.doi.org/10.1016/S0140-6736(06)68580- 2.
21. McGuire M, Munyenyembe T, Szumilin E, Heinzelmann A, Le Paih M, Bouithy N, Pujades-Rodriguez M. 2010. Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop. Med. Int. Health 15 (Suppl 1) : S55-S62. http://dx.doi.org/10.1111/j.1365-3156.2010.02504.x.
22. Ahoua L, Guenther G, Pinoges L, Anguzu P, Chaix ML, Le Tiec C, Balkan S, Olson D, Olaro C, Pujades-Rodríguez M. 2009. Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.BMC Infect. Dis. 9:81. http://dx.doi.org/10.1186/1471-2334-9-81.
23. van Rensburg EJ, Tait K, Watt A, Schall R. 2011. Comparative evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 version 2 test using the TaqMan 48 analyzer and the Abbott RealTime HIV-1 assay. J. Clin. Microbiol. 49:377-379. http://dx.doi.org/10.1128/JCM.01285-10.